Plasmepsin group of enzymes are key enzymes in the life cycle of malarial parasites. As inhibition of plasmepsins leads to the parasite's death, these enzymes can be utilized as potential drug targets. Although many drugs are available, it has been observed that Plasmodium falciparum, the species that causes most of the malarial infections and subsequent death, has developed resistance against most of the drugs. Based on the cleavage sites of hemglobin, the substrate for plasmepsins, we have designed two compounds(p-nitrobenzoyl-leucine-beta-alanine andp-nitrobenzoyl-leucine-isonipecotic acid), synthesized them, solved their crystal structures and studied their inhibitory effect using experimental and theoretical (docking) methods. In this ...
Comparative protein modeling, active site analysis and binding site specificity for the homologous s...
Novel and potent inhibitors of Plasmodium falciparum plasmepsin II were identified by post-processin...
Plasmodium parasites, the causative agents of malaria, have developed resistance to most of our curr...
Plasmepsin group of enzymes are key enzymes in the life cycle of malarial parasites. As inhibition o...
Malaria is a deadly disease killing worldwide hundreds of thousands people each year and the respons...
Malaria is one of the major public health problems in the world. Approximately 500 million people ar...
Plasmepsins (Plms) are aspartic proteases involved in the degradation of human hemoglobin by Plasmod...
Though different species of the genus Plasmodium may be responsible for malaria, the variant caused ...
accepted in Journal of Chemical Information ModelingThough different species of the genus Plasmodium...
Plasmepsins (Plms) are aspartic proteases involved in the degradation of human hemoglobin by Plasmod...
Though different species of the genus Plasmodium may be responsible for malaria, the variant caused ...
Identification of potential drug targets as well as development of novel antimalarial chemotherapies...
Antimalarial hit 1 SR (TCMDC-134674) identified in a GlaxoSmithKline cell based screening campaign w...
Antimalarial hit 1SR (TCMDC-134674) identified in a GlaxoSmithKline cell based screening campaign wa...
AbstractThe plasmepsin proteases from the malaria parasite Plasmodium falciparum are attracting atte...
Comparative protein modeling, active site analysis and binding site specificity for the homologous s...
Novel and potent inhibitors of Plasmodium falciparum plasmepsin II were identified by post-processin...
Plasmodium parasites, the causative agents of malaria, have developed resistance to most of our curr...
Plasmepsin group of enzymes are key enzymes in the life cycle of malarial parasites. As inhibition o...
Malaria is a deadly disease killing worldwide hundreds of thousands people each year and the respons...
Malaria is one of the major public health problems in the world. Approximately 500 million people ar...
Plasmepsins (Plms) are aspartic proteases involved in the degradation of human hemoglobin by Plasmod...
Though different species of the genus Plasmodium may be responsible for malaria, the variant caused ...
accepted in Journal of Chemical Information ModelingThough different species of the genus Plasmodium...
Plasmepsins (Plms) are aspartic proteases involved in the degradation of human hemoglobin by Plasmod...
Though different species of the genus Plasmodium may be responsible for malaria, the variant caused ...
Identification of potential drug targets as well as development of novel antimalarial chemotherapies...
Antimalarial hit 1 SR (TCMDC-134674) identified in a GlaxoSmithKline cell based screening campaign w...
Antimalarial hit 1SR (TCMDC-134674) identified in a GlaxoSmithKline cell based screening campaign wa...
AbstractThe plasmepsin proteases from the malaria parasite Plasmodium falciparum are attracting atte...
Comparative protein modeling, active site analysis and binding site specificity for the homologous s...
Novel and potent inhibitors of Plasmodium falciparum plasmepsin II were identified by post-processin...
Plasmodium parasites, the causative agents of malaria, have developed resistance to most of our curr...